Recombinant bone morphogenetic protein 2
Production of recombinant human bone morphogenetic protein 2 at the company's own facilities.
R&D
Noricum is a spin-off of the Tissue Engineering and Bone Regeneration Group at the Complutense University of Madrid. Research is not a department here: it is where the company came from.
Noricum was born as a result of the research activity of the Tissue Engineering and Bone Regeneration Group at the Complutense University of Madrid. Since its foundation in September 2004, its research lines have adapted to the needs of each moment, with one constant goal: bringing bone morphogenetic proteins to real clinical application.
The work began with the protein. Developing in-house protocols for the cloning, expression, folding and purification of BMPs made it possible to obtain active dimeric protein at high yields. The advantage of those protocols is not only the yield: no organic solvents or detergents are used in the folding process, which lowers the cost and makes further experimentation viable.
Then came the carrier. A protein on its own is of no use if it does not reach where it has to reach: a biomaterial capable of releasing it in vivo was needed. The result was a film with a high capacity for cell adhesion that retains rhBMP-2 in active form on its surface.
The work helped to develop a biomaterial in the shape of a film that has a high capacity for cell adhesion and is also able to retain on its surface the rhBMP-2 in active form.

Noricum is founded out of the Tissue Engineering and Bone Regeneration Group at the Complutense University of Madrid.
In-house protocols for cloning, expression, folding and purification, with no organic solvents or detergents in the folding step.
Spanish patent PE20002057, filed as PCT/ES01/00322. It passed the State of the Matter examination by the European Patent Office, which recognised the inventive activity.
Registered as a manufacturer and marketer of medical devices with the Ministry of Health, with facilities to produce the recombinant protein and to coat implants and 3D matrices.
The biomaterial
Scanning electron microscopy of the regeneration material: the porous structure is what allows cells to colonise the graft and the protein to stay retained on the surface.

Research lines
Production of recombinant human bone morphogenetic protein 2 at the company's own facilities.
Two products, one derived from the other.
Iso-bone®
Bovine bone mineral for bone regeneration.
Proteo-Graft™
A combination product: a bovine bone mineral matrix loaded with rhBMP-2.

What was measured
Experiment in a rabbit tibia to test the increase in bone height with implants coated with the rhBMP-2 film. In the image, control on the left and test on the right.
A 3 mm increase in bone height
Preclinical result in an animal model. It does not constitute a clinical indication.
Installed capacity
Production and distribution of bone morphogenetic protein 2 for research use, at an affordable cost because it is manufactured in our own facilities.
Clean rooms available for other companies to outsource trials and processes.